Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic ...

The US Food and Drug Administration (FDA) has approved the Abbott's FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals to use with ...

The FDA has approved Abbott’s FreeStyle Libre Pro continuous glucose monitoring system for clinicians to use with diabetic patients. While Abbott markets a consumer version of the FreeStyle Libre in ...

For the FreeStyle Libre Pro, which just got US clearance in September, the doctor uses a special NFC reader at the end of the monitoring period. And while the doctor recieves 14 days of continuous ...

The FDA today authorized Abbott’s (ABT) FreeStyle Libre Pro system, which is used to continually monitor diabetic patients’ glucose levels. The health care company’s FreeStyle Libre Pro system ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

The Food and Drug Administration recently approved the FreeStyle Libre Pro system, a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott. To use the system, clinicians ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...

SAN FRANCISCO--(BUSINESS WIRE)--Ambrosia announced the availability of LinkBluCon App on Fitbit platform. Now Ambrosia's NightRider BluCon and LinkBluCon app users can use Fitbit Ionic, Versa and ...

Abbott's FreeStyle Libre Flash glucose monitoring system--Courtesy of Abbott Diabetes care at Abbott Laboratories ($ABT) has returned to sales growth as ex-U.S. sales ...